X4 Pharmaceuticals Stock (NASDAQ: XFOR) stock price, news, charts, stock research, profile.
Open | $0.78 |
Close | $0.83 |
Volume / Avg. | 2.00M / 3.01M |
Day Range | 0.77 - 0.85 |
52 Wk Range | 0.53 - 1.90 |
Market Cap | $139.09M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 8.34% |
Days to Cover | 3.08 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of X4 Pharmaceuticals (NASDAQ:XFOR) through any online brokerage.
Other companies in X4 Pharmaceuticals’s space includes: Galectin Therapeutics (NASDAQ:GALT), CytomX Therapeutics (NASDAQ:CTMX), FibroGen (NASDAQ:FGEN), Tevogen Bio Holdings (NASDAQ:TVGN) and Agenus (NASDAQ:AGEN).
There is no analysis for X4 Pharmaceuticals.
X4 Pharmaceuticals has a consensus price target of $4.50.
The stock price for X4 Pharmaceuticals (NASDAQ: XFOR) is $0.8282 last updated July 23, 2024 at 6:14 PM EDT.
There are no upcoming dividends for X4 Pharmaceuticals.
X4 Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for X4 Pharmaceuticals.
X4 Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.